WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of ISTA PHARMACTLS (ISTA)

Name ISTA PHARMACTLS
Year low 2.88
Year High 11.39
Symbol ISTA
Last trade 8.17
Percentage change -0.12
Volume 154,564
Media Volume (3m) 437,994
PE Ratio N/A
EPS -1.337
Market Cap 339
Media fatt 153
Trend fatt trend fatt graph for ISTA PHARMACTLS
Media net income -54
Trend net income trend net income for ISTA PHARMACTLS
P / E P / E graph for ISTA PHARMACTLS - 0 points 0
EPS EPS graph for ISTA PHARMACTLS - 0 points 0
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for ISTA PHARMACTLS - 4 points 4
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for ISTA PHARMACTLS - 7 points 7
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for ISTA PHARMACTLS - 12 points 12
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for ISTA PHARMACTLS - 0 points 0
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for ISTA PHARMACTLS - 0 points 0
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for ISTA PHARMACTLS - 6 points 6
NET INC1/NET INC3 net inc1/net inc3 graph for ISTA PHARMACTLS - 10 points 10
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for ISTA PHARMACTLS - 3 points 3
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for ISTA PHARMACTLS - 9 points 9
. . graph for ISTA PHARMACTLS -  points
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for ISTA PHARMACTLS - 4 points 4
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for ISTA PHARMACTLS - 2 points 2
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for ISTA PHARMACTLS - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for ISTA PHARMACTLS - 0 points 0
. . graph for ISTA PHARMACTLS -  points
SELL HOLD BUY SELL           HOLD          BUY graph for ISTA PHARMACTLS - 0 points 0
SINTESE 57

GRAPHS

max price logarithm graph for ISTA PHARMACTLS based on no conditions max volume linear graph for ISTA PHARMACTLS based on no conditions

News

ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - (Jan 30 - reuters) Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc. (Jan 30 - reuters) Valeant sweetens takeover bid, ISTA shares surge (Jan 17 - reuters) UPDATE 2-ISTA says Valeant raises offer price (Jan 17 - reuters) ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan (Jan 17 - reuters) Valeant Pharmaceuticals Increases Proposed Price for Acquisition of ISTA Pharmaceuticals Inc. to $7.50 Per Share in Cash (Jan 17 - reuters) UPDATE 1-ISTA says Valeant raises offer price (Jan 17 - reuters) ISTA's Board of Directors to Review Valeant's Revised Proposal as Part of Its Ongoing Review of Strategic Options (Jan 17 - reuters) Valeant Bid Opens Eyes On ISTA Pharmaceuticals' Value (Dec 30 - reuters) 3 Stocks Shaking the Market (Dec 19 - reuters) 5 Stocks Posting Big Jumps Last Week (Dec 19 - reuters) This Week's Top Stock Gainers (Dec 17 - reuters) 5 Stocks Under $10 Set to Soar (Dec 16 - reuters) The Law Firm of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection With a Merger Proposal by Valeant Pharmaceuticals International, (Dec 16 - reuters) Bernstein Liebhard LLP Announces Investigation of Offer for ISTA Pharmaceuticals, Inc. (Dec 16 - reuters) 17 High-Growth Healthcare Stocks Being Bought Up By Hedge Funds (Nov 20 - reuters) ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results (Nov 01 - reuters) ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results (Oct 18 - reuters) ISTA Pharmaceuticals Reports Results From the Second of Two Studies in the REMURA(TM) Phase 3 Clinical Program for Dry (Oct 13 - reuters) ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM) (Oct 13 - reuters) UPDATE 1-Ista eye drug trials show mixed results (Oct 13 - reuters) Pilot Study Suggests Bromfenac (XIBROM(TM)) May Provide Added Efficacy Over Ranibizumab (LUCENTIS(R)) Alone for (Sep 07 - reuters) ISTA Pharmaceuticals to Present at Southern California Investor Conference and Stifel Nicolaus Annual Healthcare (Aug 18 - reuters) UPDATE 1-Ista's higher-dose eye drug application hits roadblock (Aug 02 - reuters) ISTA Shedding Tears on Remura Failure (Aug 01 - reuters) 5 Stocks on the Move on Friday (Aug 01 - reuters) ISTA Pharmaceuticals Reports Results From the First of Two Trials in the REMURA(TM) Phase 3 Clinical Program for Dry (Jul 28 - reuters) ISTA Pharmaceuticals Reports Second Quarter 2011 Financial Results (Jul 28 - reuters) UPDATE 1-Ista Pharma dry eye drug fails in late-stage trial (Jul 28 - reuters) ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2011 Financial Results (Jul 15 - reuters) » More ISTA.W Market Views (Jul 15 - reuters) ISTA Pharmaceuticals Announces Company's Addition to Russell 3000 and NASDAQ Biotechnology Indexes (Jun 16 - reuters) UPDATE 1-Mylan launches generic of Ista's twice-daily eye drug (May 16 - reuters) Semi-Annual Changes to the NASDAQ Biotechnology Index (May 16 - reuters) ISTA Pharmaceuticals Reports First Quarter 2011 Financial Results (May 05 - reuters) UPDATE 1-Ista Pharma says nasal spray effective in mid-stage study (Apr 28 - reuters) ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of Bepotastine Besilate Nasal (Apr 28 - reuters) ISTA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference (Apr 27 - reuters) ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2011 Financial Results (Apr 20 - reuters) ISTA Pharmaceuticals Highlights BEPREVE(R) Clinical Data at the 2011 American Academy of Allergy, Asthma and Immunology (Apr 15 - reuters) The Debt Dogs of Pharmaceuticals (Apr 15 - reuters) Stock Wrap: The Real Story, March 18 (Apr 15 - reuters) 3 Magnificent Microcaps (Apr 15 - reuters) 31 Undervalued Small Caps (Apr 15 - reuters) » More ISTA.W Market Views (Apr 15 - reuters) ISTA Pharmaceuticals Files Citizen Petition (CP) With U.S. Food and Drug Administration (Apr 15 - reuters) ISTA Pharmaceuticals to Present at 2011 RBC Capital Markets' Healthcare Conference and Cowen and Company's 31st Annual (Apr 15 - reuters) Is Alcon a Sell? (Apr 15 - reuters) ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis (Apr 15 - reuters) ISTA Pharmaceuticals Announces 2011 Guidance and Pipeline Update Webcast/Conference Call on January 5, 2011 (Apr 15 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY